Supplementary Figure S3 from Spatial Transcriptomics Advances the Use of Canine Patients in Cancer Research: Analysis of Osteosarcoma-Bearing Pet Dogs Enrolled in a Clinical Trial | Synapse
July 15, 2025
Supplementary Figure S3 from Spatial Transcriptomics Advances the Use of Canine Patients in Cancer Research: Analysis of Osteosarcoma-Bearing Pet Dogs Enrolled in a Clinical Trial
Key Points
The research uses spatial transcriptomics to analyze tissue samples from dogs with osteosarcoma.
PCA results indicate significant differences in DFI levels between the top and bottom tertiles of samples.
Canine patients enrolled in a clinical trial provide valuable data for understanding cancer development.
Findings advance the field of cancer research by highlighting the importance of using pet patients for analysis.
Abstract
Supplementary Figure 3. PCA of samples in the top and bottom tertile indicated as High and Low DFI, respectively.